Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

REFERENCES
Davies K. J. (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301–
190
310.
Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M. and Kopin I. J.
(1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
Psychiatry Res. 1, 249-254.
Dawson T. M. and Dawson V. L. (2003) Rare genetic mutations shed light on the pathogenesis
of Parkinson disease. J. Clin. Invest. 111, 145–151.
de Lau L. M. and Breteler M. M. (2006) Epidemiology of Parkinson’s disease. Lancet Neurol. 5,
525–535.
de Lau L. M., Giesbergen P. C., de Rijk M. C., Hofman A., Koudstaal P. J. and Breteler M. M.
(2004) Incidence of parkinsonism and Parkinson disease in a general population: the
Rotterdam Study. Neurology 63, 1240–1244.
de Rijk M. C., Breteler M. M., Graveland G. A., Ott A., Grobee D. E., van der Meché F. G. and
Hofman A. (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study.
Neurology 45, 2143–2146.
de Rijk M. C., Rocca W. A., Anderson D. W., Melcon M. O., Breteler M. M. and Maraganore D.
M. (1997a) A population perspective on diagnostic criteria for Parkinson’s disease.
Neurology 48, 1277–1281.
de Rijk M. C., Tzourio C., Breteler M. M., Dartigues J. F., Amaducci L., Lopez-Pousa S.,
Manubens-Bertran J. M., Alpérovitch A. and Rocca W. A. (1997b) Prevalence of
parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study.
European Community Concerted Action on the Epidemiology of Parkinson's disease, J.
Neurol. Neurosurg. Psychiatry 62, 10–15.
Deloncle R., Huguet F., Babin P., Fernández B., Quellard N. and Guillard O. (1999) Chronic
administration of aluminium L-glutamate in young mature rats: effects on iron levels and
lipid peroxidation in selected brain areas. Toxicol. Lett. 104, 65–73.